Caplin Point Laboratories Ltd

NSE: CAPLIPOINT BSE: 524742

₹1690.10

(0.36%)

Sun, 15 Mar 2026, 04:33 pm

MTF 5xInvest in Caplin Point Laboratories Ltd with 5x Leverage Buy with MTF

Market Cap128.05B

PE Ratio21.00

Dividend0.36

Health Technology

Pharmaceuticals: Major

24.5K

Caplin Point Laboratories EV/EBITDA Ratio

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2006	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Price to earnings ratio	9.29	15.70	6.01	6.32	5.37	4.87	5.08	12.94	25.06	30.68	30.06	17.32	10.01	12.73	17.32	12.13	21.99	28.51
Price to book ratio	0.96	0.50	0.56	0.83	1.16	1.16	1.65	5.42	11.92	13.05	11.91	4.81	2.25	2.58	3.47	2.41	4.32	5.48
Price to sales ratio	0.36	0.25	0.23	0.36	0.43	0.37	0.58	1.98	4.95	7.52	8.28	4.83	2.55	2.94	4.11	3.14	5.99	7.96
Price to cash flow ratio	6.67	15.26	1.07	32.35	2.34	1.33	2.11	5.85	34.26	40.03	60.64	36.09	44.24	11.10	14.60	15.35	27.82	31.62
Enterprise value	166.39M	132.28M	50.16M	168.37M	220.17M	141.15M	589.68M	3.11B	14.62B	28.38B	42.69B	28.36B	19.16B	26.5B	47.06B	39.45B	92.95B	145.02B
Enterprise value to EBITDA ratio	5.30	6.59	1.60	6.93	3.57	1.12	2.87	8.86	18.31	24.91	23.57	13.12	7.90	8.26	11.96	9.09	17.19	22.62
Debt to equity ratio	0.49	0.51	0.36	0.41	0.33	0.21	0.11	0.05	0.02	0	0	0	0.04	0.02	0	0	0	0
Return on equity %	0	0	9.78	13.52	23.05	25.57	36.46	49.29	64.23	54.19	49.25	35.43	27.20	22.71	22.46	22.37	21.79	20.76

Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio

The Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Caplin Point Laboratories Ltd's valuation, profitability, and overall financial performance. Tracking the Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Caplin Point Laboratories Ltd (NSE: CAPLIPOINT, BSE: 524742) is currently trading at ₹1690.10, with a market capitalization of ₹128.05B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio Current Value

The current Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio stands at 22.62.

The latest Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

2024: 22.62
2023: 17.19
2022: 9.09
2021: 11.96
2020: 8.26

The recent rise in Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio suggests strengthening valuation trends and improving market sentiment.

What Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Caplin Point Laboratories Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800